Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out

Scroll down and select country
MEBO TMAU TESTING CURRENTLY SUSPENDED INDEFINITELY

MEBO - UBIOME study 2018

'PRESS RELEASE'

NCT03582826
ClinicalTrials.gov

MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production
& PATM

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person

NO LONGER RECRUITING

Participation info : LINK English

MEBO Map Testing & Meetups


Full details : https://goo.gl/TMw8xu
want listed ? contact info@meboresearch.org

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts

MEBO TMAU Videos

Petitions

TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study
NCT02683876

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned


Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
EURORDIS and
NORD Member Organization
See RareConnect

Popular Posts (last 30 days)

Upcoming get-togethers


Let us know if you want a meetup listed

Subscribe to Blog

Enter your email address:

Delivered by FeedBurner

You will be sent a verification email

Subscribe in a reader

Blog Archive

MEBO Research Clinical Trials

Click here to read details of the MEBO Clinical Trials
NCT03582826 - Ongoing not recruiting
Microbial Basis of Systemic Malodor and PATM Conditions (PATM)
United States 2018 - ongoing

NCT02683876 - Completed
Exploratory Study of Relationships Between Malodor and Urine Metabolomics
Canada and United States 2016 - ongoing

NCT03451994 - Completed
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
United Kingdom and United States 2013 - ongoing

NCT02692495 - Completed
Evaluation of Potential Screening Tools for Metabolic Body Odor and Halitosis
United Kingdom 2009 - 2012

Friday, August 5, 2016

Clinical Trials MEBO Metabolomic Study for Malodor


Canadian Volunteers Needed
for Metabolomics Malodor Pilot Study

On February 2016, MEBO received the approval from ClinicalTrials.gov with Identifier, NCT02683876, so that we may to commence the Exploratory Study of Relationships Between Malodor and Urine Metabolomics, Sponsored by MEBO Research, Inc., with the University of Alberta, Canada as Collaborator. The aim of this study is the metabolomic profiling of urine samples for the identification of novel biomarkers, metabolic signatures associated with malodor conditions, and mechanisms in the diagnosis and management of malodor associated with metabolic inefficiencies. The investigators will perform state-of-the art metabolomics tests and bioinformatic data mining to explore whether conditions leading to malodor can be screened by metabolomic profiling of urine samples.

MEBO's Scientific Director, Irene Gabashvili, PhD. is representing MEBO as the registered U.S. Principal Investigator of this study, and she is collaborating with the registered Principal Investigator, David Wishart, PhD, and his staff of the Metabolomics Innovation Centre (TMIC) of the University of Alberta, in Edmonton, Canada.

All recruitment will be performed exclusively by MEBO.

Anyone interested in participating in this program can express interest by email tomaria.delatorre@meboresearch.org. Please provide your legal name, address, and email address where you will be contacted to be invited to participate in the study. At the present time, the pilot study is commencing involving participants who reside in Canada and suffer from a malodor condition, and based on results, may expand to include sufferers from other countries. If you qualify and are interested in being a participant in the pilot study and have not yet been contacted, please express interest to the email above.

Metabolic profiles will be identified using the metabolomics equipment located in the NMR, HPLC, and MS facilities of the Metabolomics Innovation Centre (TMIC).
In this study, metabolite profiling analysis will be carried out on urine samples of individuals with malodor conditions related to metabolism inefficiencies. Metabolic profiles will be identified using the metabolomics equipment located in the NMR, HPLC, and MS facilities of the Metabolomics Innovation Centre (TMIC). Multivariate statistical analyses will be used, as well as other approaches to mine complex data from heterogeneous sources.


For more information on this program, please see posts in this blog under tag, ‘Metabolomic Malodor Study’ and scroll down to see all posts.

In an effort to maintain the integrity of the study, the staff at TMIC will not have any of your personal information, and you may be disqualified from the study if you contact the lab directly and divulge personal information.
Confidentiality is of the utmost importance to MEBO and to this study. All information will remain confidential, and no one outside the MEBO staff in charge of this program will not have access to any of your personal information. In an effort to maintain the integrity of the study, the staff at TMIC will not have any of your personal information, and you may be disqualified from the study if you contact the lab directly and divulge personal information. All contact must be made through MEBO exclusively. Your cooperation in this matter would be greatly appreciated.



María de la Torre
Founder and Executive Director

A Public Charity
www.meboresearch.org
www.brasil.meboresearch.org
maria.delatorre@meboresearch.org
MEBO's Blog (English)
El Blog de MEBO (español)
MEBO Brasil - Blog (Portuguese)



SUPPORT THE MEBO MISSION: Click Amazon button at right sidebar of this blog when shopping online for the holidays
at no extra cost to you.
MEBO gets small commission from Amazon.


Please use your credit card to make your donation to MEBO.


Subscribe for latest posts : Enter your email address:

Delivered by FeedBurner


A EURORDIS and NORD Member Organization

10 comments:

Anonymous said...

Hi sorry this is off topic but is there any reason why the rareconnect website isn't working?

Aug 7, 2016, 4:32:00 PM
blogcontributor2 said...

Hi. It's probably being updated. Don't have any info but I wouldn't worry about it disappearing. They have good funding etc. Probably back tomorrow.

Aug 7, 2016, 5:05:00 PM
Anonymous said...

Oh that's good ��

Aug 7, 2016, 5:45:00 PM
Stephanie said...

Any update on trinzyme?

Aug 8, 2016, 11:21:00 PM
Maria de la T., Founder and Executive Director, MEBO Research said...

The scientists are still pursuing significant funding (approximately $10 million US dollars) for the Clinical Trials phase. They are pursuing government and private grants. Once that has been achieved, I will post about it and the commencement of the Clinical Trials.

Aug 10, 2016, 2:00:00 PM
Stephanie said...

I'm glad to hear they are still pursuing grant money and that the project hasn't been dropped. Wish there was more we could do as a group...

Aug 11, 2016, 5:21:00 PM
Anonymous said...

Lets pray they get it :)

Aug 11, 2016, 9:07:00 PM
Anonymous said...

any reunion coming soon?

Aug 13, 2016, 10:43:00 PM
Anonymous said...

Have they found the grant and just working through legal procedures or still lookin for grants?

Aug 17, 2016, 6:23:00 PM
Maria de la T., Founder and Executive Director, MEBO Research said...

We won't be informed until the process is finalized. There were some interested leads, but we don't know how it's going. Sorry.

Aug 18, 2016, 6:38:00 PM
Post a Comment